ATH alterity therapeutics limited

Ionis ION464

  1. 5,999 Posts.
    lightbulb Created with Sketch. 162
    They are testing ION464 for MSA and Parkinson's and have it listed with phase 2 trials. It is a Biogen(BIIB) trial. On Ionis pipeline page.
    This is from the Ionis site-
    [ This investigational antisense oligonucleotide medicine is in a Phase 1 study. It is listed here as a Phase 2 because the medicine is being tested in patients and not healthy volunteers ]

    I have never seen that done before.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $119.6M
Open High Low Value Volume
1.1¢ 1.1¢ 1.0¢ $46.86K 4.283M

Buyers (Bids)

No. Vol. Price($)
64 25268416 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 18128695 9
View Market Depth
Last trade - 16.10pm 19/09/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.